PARG and familial pancreatic carcinoma: A recent study from Shirai et al. (22) also reported an S-phase arrest and an increase in DSB formation in Parg−/− mouse ES cells or PARG knockdown pancreatic cancer cells treated with an alkylating agent which leads to high PAR levels in these PARG-deficient cells.